Protein X (HBx), a key viral oncoprotein encoded by HBV, can lead to upregulation of its activity and promote tumor growth after specific ubiquitination by male-specific lethal 2 (MSL2), whereas antiviral therapy can significantly reduce HBx mRNA expression in tumor tissues and slow down tumor progression [35]. Here, REG1A is linked to neoplasm.